Rabies Prevention for Travellers: Canada’s Advice Weighs Destination and Access to Care
Canadian travel-health guidance recommends assessing both rabies risk at the destination and whether prompt post-exposure care will be available. Updated NACI schedules and CATMAT’s traveller-specific advice support a more individualized pre-travel discussion—not a blanket recommendation for every trip.
In this article & details
Canadian guidance on rabies prevention for travellers puts two questions together: how likely is an exposure on the planned trip, and how accessible would urgent treatment be if one occurs? The Public Health Agency of Canada’s Committee to Advise on Tropical Medicine and Travel (CATMAT) advises clinicians to consider pre-exposure vaccination (PrEP) for people travelling to places with relatively higher rabies risk where rabies immunoglobulin may not be readily available.
That is a discretionary recommendation, not a direction to vaccinate every traveller. CATMAT asks health professionals to consider the destination, itinerary, activities and access to care, then discuss potential benefits and harms in light of the traveller’s preferences. Country-specific information is available in federal travel-health advice.
Updated schedules depend on risk and duration
In January 2026, the National Advisory Committee on Immunization (NACI) grouped people for whom PrEP is recommended into very-high-, high- and moderate-risk categories. The categories distinguish situations such as potentially unrecognized occupational exposure from exposures that may occur during travel or other activities. Schedules and follow-up serology differ by risk group and immune status.
For some immunocompetent travellers whose risk is expected to last less than three years, NACI says a two-dose primary series may be used. People with longer or uncertain risk, and people in other risk categories, may have different schedules or a later booster; immunocompromised people have specific recommendations. These schedules should be checked against the current federal guidance and product information rather than inferred from a general travel checklist.
The new risk categories are not a simple country ranking. A traveller’s exposure depends on what they will do, how long they will be away and whether they could reach care promptly. A short urban stay with little animal contact is different from extended work outdoors or travel to a remote area where treatment supplies may be difficult to obtain. Immunocompromise can also change the recommended schedule and follow-up.
For people at very high or high risk because exposures could go unnoticed, NACI recommends a three-dose primary series and periodic antibody testing. For some moderate-risk situations, monitoring and booster advice depend on how long the risk is expected to continue. Clinicians should consult the current table rather than apply the traveller schedule to occupational or laboratory exposures.
Pre-travel vaccination does not remove the need to act after a possible exposure. NACI says previously vaccinated people should still seek post-exposure prophylaxis (PEP). Immediate, thorough wound washing and prompt clinical assessment remain important. Prior vaccination generally simplifies the PEP regimen, but it is not a reason to delay care or decide on one’s own that treatment is unnecessary.
What to discuss before departure
A practical assessment includes where the traveller will stay, time in rural or remote areas, planned animal contact, work or recreation that could bring them near mammals, trip length, ability to reach medical care and whether rabies immunoglobulin would be obtainable locally. Travellers should be reminded not to handle unfamiliar domestic or wild animals and to learn where to seek care if bitten, scratched or exposed to saliva on broken skin.
Role for pharmacy teams
Pharmacists who provide travel-health services can help identify when a rabies discussion is warranted, check vaccine records and timing, explain that a pre-travel series is not a substitute for PEP, and refer complex questions—such as immunocompromise, prior rabies vaccination or a significant exposure—to the appropriate clinician. The final decision should reflect current guidance, local scope and the traveller’s circumstances.
It is also useful to give travellers a clear action plan: avoid animal contact, wash a wound immediately after a bite or scratch, and seek medical assessment without delay. PEP decisions are urgent and should be made with a clinician familiar with current recommendations and local access to vaccine and immunoglobulin.
The core message is not that every trip requires rabies vaccination. It is that risk is shaped by both exposure and the ability to obtain prompt, appropriate care afterward. A focused conversation before departure can help travellers make an informed plan.
Primary sources
References
- CATMAT traveller rabies PrEP statement (2026) — Public Health Agency of Canada, Official traveller-specific recommendation and decision framework.
- NACI: Updated guidance for rabies vaccine PrEP (2026) — Public Health Agency of Canada, Risk-group recommendations, schedules and post-exposure advice.
- Canadian Immunization Guide: Rabies vaccines — Public Health Agency of Canada, Current Canadian vaccine information and clinical context.
